Naloxone must become available through take-home programs without the need for doctor or pharmacist involvement, say Australian experts in a report published in the Medical Journal of Australia. The drug was recently downscheduled to Pharmacist Only following an application to the TGA by Brunswick pharmacist and PSA Harm Minimisation Committee member Angelo Pricolo. Professor Simon
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.